350 related articles for article (PubMed ID: 20507274)
1. Do statins beneficially or adversely affect glucose homeostasis?
Kostapanos MS; Liamis GL; Milionis HJ; Elisaf MS
Curr Vasc Pharmacol; 2010 Sep; 8(5):612-31. PubMed ID: 20507274
[TBL] [Abstract][Full Text] [Related]
2. Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.
Arnaboldi L; Corsini A
Atheroscler Suppl; 2015 Jan; 16():1-27. PubMed ID: 25575403
[TBL] [Abstract][Full Text] [Related]
3. Statins and their increased risk of inducing diabetes.
Agouridis AP; Kostapanos MS; Elisaf MS
Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
5. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
Kostapanos MS; Milionis HJ; Elisaf MS
Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
[TBL] [Abstract][Full Text] [Related]
7. Differential metabolic effects of distinct statins.
Koh KK; Sakuma I; Quon MJ
Atherosclerosis; 2011 Mar; 215(1):1-8. PubMed ID: 21130454
[TBL] [Abstract][Full Text] [Related]
8. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea.
Kim J; Lee HS; Lee KY
Cardiovasc Diabetol; 2018 Dec; 17(1):155. PubMed ID: 30518364
[TBL] [Abstract][Full Text] [Related]
9. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
11. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
Schachter M
Fundam Clin Pharmacol; 2005 Feb; 19(1):117-25. PubMed ID: 15660968
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.
Gotto AM; Moon J
Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1079-90. PubMed ID: 20670185
[TBL] [Abstract][Full Text] [Related]
13. Statins: beneficial or adverse for glucose metabolism.
Sasaki J; Iwashita M; Kono S
J Atheroscler Thromb; 2006 Jun; 13(3):123-9. PubMed ID: 16835466
[TBL] [Abstract][Full Text] [Related]
14. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.
Kawai Y; Sato-Ishida R; Motoyama A; Kajinami K
Drug Des Devel Ther; 2011; 5():283-97. PubMed ID: 21625418
[TBL] [Abstract][Full Text] [Related]
15. The good and bad effects of statins on insulin sensitivity and secretion.
Muscogiuri G; Sarno G; Gastaldelli A; Savastano S; Ascione A; Colao A; Orio F
Endocr Res; 2014; 39(4):137-43. PubMed ID: 25208056
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
17. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
Ma T; Tien L; Fang CL; Liou YS; Jong GP
Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
[TBL] [Abstract][Full Text] [Related]
18. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
[TBL] [Abstract][Full Text] [Related]
19. Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus.
Yamakawa T; Takano T; Tanaka S; Kadonosono K; Terauchi Y
J Atheroscler Thromb; 2008 Oct; 15(5):269-75. PubMed ID: 18981652
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?
Chan DC; Pang J; Watts GF
Curr Atheroscler Rep; 2015 Jan; 17(1):472. PubMed ID: 25398645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
